This Week at FDA: RTO challenges, measles response criticism, and FDA’s new infant formula plan

This Week at FDA

This Week at FDAFerdous Al-Faruque

Biologics/ biosimilars/ vaccinesGovernment/legislationMedical DevicesPharmaceuticalsRegulatory Intelligence/PolicyUnited StatesUS Food and Drug Administration (FDA)Warning letters